This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Dr. Sridhar Govindarajan, PhD
CIO and Co-Founder at ATUM
Speaker

Profile

ATUM’s Co-founder and CIO, Dr. Sridhar Govindarajan leads computataional, engineering, security and automation efforts – including developing AI methods for Antibody Engineering. Prior to founding ATUM, Dr. Govindarajan held positions at Maxygen and Eragen Biosciences. His thesis on protein folding and evolution laid the groundwork for ATUM’s GPS technologies. Dr. Govindarajan received his PhD in Computational Chemistry/Biophysics from the University of Michigan and holds an undergraduate degree from Indian Institute of technology, Bombay.

Agenda Sessions

  • Optimizing Antibodies and Related Protein Therapeutics: Bridging AI, Experimental Designs and Developability

    1:15pm